Implications of 60-day dispensing for pharmacies
As we know from the Federal Budget 2023, significant changes are proposed for Australia’s pharmaceutical landscape, commencing September 1, 2023.
Eligible patients with chronic conditions will have the option to purchase two months’ (60-days) worth of commonly prescribed medicines (PBS listed) for the price of a single prescription. While the Government’s change brings perceived consumer benefits in reduced prescription fees, it brings with it a range of concerns for pharmacists, their businesses and the community.